Development and Validation of Stability Indicating Method for Capecitabine

Enregistré dans:

Détails bibliographiques
Auteur principal:	Agarwal Ayushi
Format:	Thèse Livre
Langue:	anglais
Sujets:	Quality Assurance
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Development and Validation of Stability Indicating Method for Febuxostat
par: Mohanty Rahul

Development of Validated Stability Indicating Assay Method and Study Decomposition Behavior of Erlotinib by LC-MS/MS
par: Gundecha Satyam

Development of Validated Stability Indicating Assay Method and Study Decomposition Behaviour of Lenvatinib by LC-MS/MS
par: Shah Margi

Development and Validation of Stability Indicating RP-HPLC and LC-MS/MS Method for Characterization of Forced Degradation Product of Daprodustat.
par: Patil Roshani

Qbd Enabled Development and Validation of Stability-Indicating RP-HPLC Method for Estimation of Eltrombopag Olamine in API and Pharmaceutical Dosage Form and Compatible LC/MS Method Development
par: Godani Nandan

Development of Stability Indicating HPLC Method and LC-MS/MS Characterization of Force Degradation Products of Tafamidis with Compatative in Silico Therapeutic and Toxicological Profile
par: Agarwal Nikhil

Development and Stability Indicating HPLC and LC-MS/MS Compatible Method for Characterization of Forced Degradation Products of Desidustat
par: Jain Sunidhi

Development of Stability Indicating HPLC and LC-MS/MS Compatible Method for Characterization of Forced Degradation Products of Mavacamten
par: Varkad Siddhanath

Simultaneous Estimation of Lobeglitazone and Glimepiride in Pharmaceutical Dosage Form and Development of Stability Indicating Method by RP-HPLC and LC-MS/MS Compatible Method for Characterization of Forced Degradation Products of Lobeglitazone
par: Mudaliar Saradhkumar

Analytical Method Development and Validation of Dapagliflozin in Bulk by HPTLC and in Dosage Form by HPLC
par: Gupta Ankit

Development and Stability Indicating HPLC and LC-MS/MS Characterization of Force Degradation Products of Imeglimin Hydrochloride with Comparative In Silico Therapeutic and Toxicologial Profile
par: Sultan Jasira

Development and Stability Indicating HPLC and LC-MS/MS Characterization of Force Degradation Products of Imeglimin Hydrochloride with Comparative In Silico Therapeutic and Toxicologial Profile
par: Sultan Jasira

Stability Study of Fosravuconazole Drug Substance and Product
par: Maliyakal Jeswin

Chemical Stability Study of Udenafil Using QbD and Green Chemistry Concept
par: Bherje Sandesh

Simultaneous Estimation of Rosuvastatin Calcium and Bempedoic Acid in Combination in Pharmaceutical Dosage Form by UV Spectroscopy and RP-HPLC and Stress Degradation Behaviour of Bempedoic Acid by Validated RP-HPLC
par: Hadawale Sakshi

Development and Evaluation of Peptide Dendrimers
par: Patil Asmita

Stability- Indicating RP- HPLC Method Development And Validation for the Estimation Opicapone in Formulation
par: Deshmukh Ishwar Ramchandra

LCMS/MS Method to Quantify Nitrosamine Impurities in the Commercial Formulation of Ivermectin
par: Ajmeri Janvi

Development and Evaluation of Orally Disintegrating Formulation of Biperiden
par: Surve Jayesh

Development of Multi Unit Particulate System of Dapagliflozin with Metformin.
par: Patel Vishwa

Development and Evaluation of Nasal Delivery of Chrysin for Treatment of Parkinson’s disease
par: Adangale Shreya

Development of Indole-Based Molecules as Potential Inhibitors of Monocarboxylate Transporter 1
par: Pawar Harshala

Development of a Novel B-Cyclodextrin Derivative for Industrial Wastewater Purification
par: Shende Himani

Design Development and Biological Evaluation of Extended - Release Formulation of Valproic Acid
par: Chavan Aditi

Development of Sustained Release Matrix Pellets of Carica Papaya Linn. Leaf Extract
par: Shaikh Fuzail Abdur Rahim

Development of New Small Molecule Inhibitors of Monocarboxylate Transporter 1 as Potential Anticancer Agents
par: Shirsat Komal

Development of Nano-Formulation Co-Delivery System for Potent MCT-1 Inhibitor S-9 and Metformin
par: Parekh Janvi

Design and Development Of Triazine Targeting Plasmodium Falciparum Dihydrofolate Reductase (PfDHFR) For Antimalarial Action
par: Marne Pranav

Development of a Magnetic β-cyclodextrin- Dianhydride Polymer Nano Adsorbent for Industrial Waste Water Purification
par: Patel Anushri

Development and Optimization of Pt@ZIF 8 by QbD Approach and Deciphering Their Antibiofilm and Anti-quorum Sensing Ability Against ESKAPE Pathogens
par: Rahate Sarvesh

Design, Synthesis and Evaluation of Indazole-3-Carboxamide Derivatives as Anticancer Agents
par: Bharuka Aashay

To Formulate and Evaluate Naltrexone Loaded Matrix Type Transdermal Patch
par: Chakraborty Varsha

Design and Synthesis Coumarin Thiazole Derivatives as α- glucosidase Inhibitors for Treatment of type II Diabetes
par: Ichale Rushikesh

New Heterocyclic Hybrids of Acridone As Promising Anti-Cancer Agents
par: Jagani Abhishek

Design, Synthesis and Evaluation of Acridone Based Oxadiazole Hybrids as Anticancer Agents
par: Shaikh Gulam Moin

Design and Synthesis of 9 Aminoacridine Derivatives in the Treatment of Alzheimer’s Disease
par: Shenoy Shirish

Design and Synthesis of di-aryl Thiazole Derivatives as α- glucosidase Inhibitors for Treatment of Type II Diabetes
par: Varma Payal

Design and Synthesis and Evaluation of New Indazole Derivatives as Anticancer Agents
par: Gangurde Saurabh

Identification, Isolation and Screening of Potent Secondary Metabolites/Fraction of Actinomycetes from Herbal Garden Soil
par: Moghe Tanvi

Design (QbD) and Risk Assessment Approach for Formulation and Evaluation of Clobetasol Proionate Nanoemulgel for Anti Psoriatic Activity
par: Devadiga Shanaika